CDXC
USDChromaDex Corporation Common Stock
$7.870-0.040 (-0.506%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
No chart data available
Key Metrics
Market Metrics
Open
$7.910
High
$7.920
Low
$7.745
Volume
N/A
Company Fundamentals
Market Cap
611.9M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.82M
Exchange
NCM
Currency
USD
52-Week Range
Low $2.305Current $7.870High $9.18
Related News
BusinessWire
ChromaDex Corp. Announces Name Change to Niagen Bioscience, Inc. and New Ticker Symbol "NAGE" Effective March 19, 2025
ChromaDex Corp. (NASDAQ:CDXC), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that it will change its corporate name to Niagen Bioscience,
View more
Analyst Upgrades
Ladenburg Thalmann Maintains Buy on ChromaDex, Raises Price Target to $8.1
Ladenburg Thalmann analyst Jeffrey Cohen maintains ChromaDex with a Buy and raises the price target from $6.8 to $8.1.
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.